Evidence map›Paper›PMID 24625093›Full record

ReviewBMC medical informatics and decision making2013

A systematic development process for patient decision aids.

Angela Coulter, Diana Stilwell, Jennifer Kryworuchko, Patricia Dolan Mullen, Chirk Jenn Ng, Trudy van der Weijden

6 registry-linked trialsAbstract readReview
In one paragraph

Review in BMC medical informatics and decision making, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 6 registered trials, which are not on this map. Cited by 349 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
349citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02344576 nacompletednot on this mapstarted 2015, after this paper: background citation

A Multicenter Trial of a Shared Decision Support Intervention for Patients and Their Caregivers Offered Destination Therapy for End-Stage Heart Failure

TypeinterventionalSponsorUniversity of Colorado, DenverRan2015 to 2018Enrolled445ConditionsHeart Failure, Heart-assist DevicesArmsDT LVAD Decision Support Intervention
NCT02558049 nacompletednot on this mapstarted 2015, after this paper: background citation

Should I Continue Taking My Acid Reflux Medication? Development and Pilot Testing of a Patient Decision Aid

TypeinterventionalSponsorUniversity of OttawaRan2015 to 2016Enrolled12ConditionsProton Pump Inhibitors, Gastroesophageal Reflux DiseaseArmsDecision aid
NCT04437069 naactive not recruitingnot on this mapstarted 2020, after this paper: background citation

Improving Patient and Family Health Using Family-Centered Outcomes and Shared Decision-Making

TypeinterventionalSponsorUniversity of UtahRan2020 to 2026Enrolled135ConditionsPatient Decision Aids, Congenital Heart Disease, Congenital Heart DefectArmsDecision Aid, Values Clarification Exercise
NCT04995796 nacompletednot on this mapstarted 2021, after this paper: background citation

Testing the Decision Aid: Supporting Patient Decisions About Upper Extremity Surgery in Cervical Spinal Cord Injury (AIM 3)

TypeinterventionalSponsorWashington University School of MedicineRan2021 to 2022Enrolled40ConditionsCervical Spinal Cord Injury, TetraplegiaArmsSurveys for Research Purposes
NCT05477420 nacompletednot on this mapstarted 2022, after this paper: background citation

A Survey Study and Effect of Web-based Decision Aids on Preferences Shift

TypeinterventionalSponsorChinese University of Hong KongRan2022 to 2024Enrolled148ConditionsDepression, PsychotherapiesArmsDecision Aid
NCT05512260 nawithdrawnnot on this mapstarted 2023, after this paper: background citation

Towards High, Equal and Informed Participation in Swedish Cancer Screening - the BESTa Project.

TypeinterventionalSponsorKarolinska InstitutetRan2023 to 2025Enrolled0ConditionsNeoplasm, Colorectal, Neoplasm, Breast, Neoplasm, OvarianArmsIndividual decision aid (iDA)
3 · Its place in the literature

Who cites it

349 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. A decision aid to support family carers of people living with dementia towards the end-of-life: Coproduction process, outcome and reflections.Health expectations : an international journal of public participation in health care and health policy · 2021
    Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Different information needs-The major reasons for calling the helpline when invited to colorectal cancer screening.Health expectations : an international journal of public participation in health care and health policy · 2022
    Trial
  14. Trial
  15. Trial
  16. Trial
  17. Article
  18. Article
  19. Article
  20. Article

289 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Angela Coulter
Diana Stilwell
Jennifer Kryworuchko
Patricia Dolan Mullen
Chirk Jenn Ng
Trudy van der Weijden

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe original version of the International Patient Decision Aid Standards (IPDAS) recommended that patient decision aids (PtDAs) should be carefully developed, user-tested and open to scrutiny, with a well-documented and systematically applied development process. We carried out a review to check the relevance and scope of this quality dimension and, if necessary, to update it.

methodsOur review drew on three sources: a) published papers describing PtDAs evaluated in randomised controlled trials and included in the most recent Cochrane Collaboration review; b) linked papers cited in the trial reports that described how the PtDAs had been developed; and c) papers and web reports outlining the development process used by organisations experienced in developing multiple PtDAs. We then developed an extended model of the development process indicating the various steps on which documentation is required, as well as a checklist to assess the frequency with which each of the elements was publicly reported.

resultsKey features common to all patient decision aid (PtDA) development processes include: scoping and design; development of a prototype; 'alpha' testing with patients and clinicians in an iterative process; 'beta' testing in 'real life' conditions (field tests); and production of a final version for use and/or further evaluation. Only about half of the published reports on the development of PtDAs that we reviewed appear to have been field tested with patients, and even fewer had been reviewed or tested by clinicians not involved in the development process. Very few described a distribution strategy, and surprisingly few (17%) described a method for reviewing and synthesizing the clinical evidence. We describe a model development process that includes all the original elements of the original IPDAS criterion, expanded to include consideration of format and distribution plans as well as prototype development.

conclusionsThe case for including each of the elements outlined in our model development process is pragmatic rather than evidence-based. Optimal methods for ensuring that each stage of the process is carried out effectively require further development and testing.

Indexed as

Decision Support TechniquesPatient ParticipationProgram DevelopmentHumans

Identifiers

PMID24625093
PMCPMC4044159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.